Comparable Efficacy and Safety of Generic Imatinib and Branded Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia With a Consideration of Socioeconomic Characteristics: A Retrospective Study From a Single Center-Reference-Cited by-同舟云学术

Comparable Efficacy and Safety of Generic Imatinib and Branded Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia With a Consideration of Socioeconomic Characteristics: A Retrospective Study From a Single Center

Published:2020-06 Issue:6 Volume:20 Page:e304-e315
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Dou Xuelin,Qin Yazhen,Lai Yueyun,Shi Hongxia,Huang Xiaojun,Jiang Qian

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference30 articles.

1. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013;Baccarani;Blood,2013

2. Journey of generic imatinib: a case study in oncology drug pricing;Chen;J Oncol Pract,2017

3. Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia;Dusetzina;J Clin Oncol,2014

4. A survey on tyrosine kinase inhibitor treatment in patients with chronic myeloid leukemia in China: from patients’ perspective;Jiang;Zhonghua Xue Ye Xue Za Zhi,2016

5. Higher out-of-pocket expenses for tyrosine kinase-inhibitor therapy is associated with worse health-related quality-of-life in persons with chronic myeloid leukemia;Jiang;J Cancer Res Clin Oncol,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparable efficacy and safety of generic and branded imatinib for patients with chronic myeloid leukemia in China;Therapeutic Advances in Hematology;2024-01

2. Are Generic Imatinib Formulations Really as Effective as Originial Imatinib in Chronic Myeloid Leukemia: Real Life Data;2022-12-09

3. Concomitant Use of Ado-trastuzumab Emtansine and Imatinib in a Patient of CML and Metastatic Breast Cancer;Journal of the College of Physicians and Surgeons Pakistan;2022-11-01

4. Current evidence on the efficacy and safety of generic imatinib in CML and the impact of generics on health care costs;Blood Advances;2021-09-03

5. Economics influences therapy decisions in chronic myeloid leukaemia: should it?;Journal of Cancer Research and Clinical Oncology;2021-04-22